Persistent and chronic opioid use after ambulatory surgery in US veterans (2011-2018)
- PMID: 39271439
- DOI: 10.1016/j.surg.2024.08.004
Persistent and chronic opioid use after ambulatory surgery in US veterans (2011-2018)
Abstract
Background: Opioid use beyond the perioperative period is a recognized adverse outcome, primarily studied in inpatients after complex major surgeries. Our goals are to determine the risk after ambulatory surgery and identify risk factors associated with long-term opioid prescriptions.
Methods: Our ambulatory surgery cohort included 1,393,332 veterans from October 1, 2011, to September 30, 2018 (fiscal year [FY] 12-18). Data included age, sex, race, rurality of patient residence and facility, body mass index, tobacco use, Charlson Comorbidity Index, psychiatric disorder, pain score at surgery, substance use, and medications (benzodiazepine, tricyclics and/or selective serotonin reuptake inhibitor and opioids in the 12 months previous).
Results: In aggregate, 9.6% had 1 or more prescriptions in the 90-180 days after surgery ("Persistent prescription[s]") and 1.8% had more than 180 days of opioids in the 31-366 days after surgery ("Chronic prescriptions"). For persistent prescription(s), trends over time decreased from 12.5% in FY12 to 7.1% by FY18 (P < .001). Similarly chronic prescriptions decreased from 2.9% in FY12 to 0.8% in FY18 (P < .001). The strongest independent association for persistent and chronic prescriptions after ambulatory surgery was previous prescription opioids, with 2.8 times increased risk for persistent prescriptions (adjusted odds ratio, 2.8; 95% confidence interval, 2.8-2.9; P < .001) and 3.3 times increased risk for chronic opioid prescriptions (adjusted odds ratio, 3.3; 95% confidence interval, 3.2-3.4; P < .001).
Conclusions: Rates of persistent and chronic opioid prescriptions after ambulatory surgery in the Veterans Health Administration are small and decreasing over time. Providers and patients should have informed discussions regarding risks of opioid postoperative pain management strategies.
Published by Elsevier Inc.
Conflict of interest statement
Conflict of Interest/Disclosure Dr Liu has no financial conflict of interest to disclose. Dr Soybel reports Up-to-Date, Inc (Editor-in-Chief: General Surgery and section editor: Upper GI surgery) and is a consultant for NanBioSym, Inc (Cambridge, MA).
Similar articles
-
Persistent Opioid Use after Ophthalmic Surgery in Opioid-Naive Patients and Associated Risk Factors.Ophthalmology. 2021 Sep;128(9):1266-1273. doi: 10.1016/j.ophtha.2021.04.021. Epub 2021 Apr 22. Ophthalmology. 2021. PMID: 33895223 Free PMC article.
-
Definition development and prevalence of new persistent opioid use following hysterectomy.Am J Obstet Gynecol. 2018 Nov;219(5):486.e1-486.e7. doi: 10.1016/j.ajog.2018.06.010. Epub 2018 Jun 19. Am J Obstet Gynecol. 2018. PMID: 29928864 Free PMC article.
-
An Opioid Prescription for Men Undergoing Minor Urologic Surgery Is Associated with an Increased Risk of New Persistent Opioid Use.Eur Urol. 2020 Jan;77(1):68-75. doi: 10.1016/j.eururo.2019.08.031. Epub 2019 Sep 18. Eur Urol. 2020. PMID: 31542305
-
Rates of New Persistent Opioid Use After Vaginal or Cesarean Birth Among US Women.JAMA Netw Open. 2019 Jul 3;2(7):e197863. doi: 10.1001/jamanetworkopen.2019.7863. JAMA Netw Open. 2019. PMID: 31348508 Free PMC article.
-
Risk factors for persistent postoperative opioid use: an entity distinct from chronic postsurgical pain.Reg Anesth Pain Med. 2025 Feb 5;50(2):121-128. doi: 10.1136/rapm-2024-105599. Reg Anesth Pain Med. 2025. PMID: 39266222 Review.
References
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources